The NYU lupus cohort study Published in Rheumatology (Oxford) by Carlucci and colleagues, this retrospective evaluation examined GLP-1 receptor agonist use within the NYU Lupus Cohort, a prospective longitudinal convenience cohort initiated in 2014 with 1,211 SLE patients
Skipping or shortening washout periods reduces the efficacy of subsequent cycles by up to 50% because of incomplete receptor recovery
Diagnosis usually begins with a clinical history, review of diet and medications, and a physical examination
Log any of the 18 most common GLP-1 side effects - nausea, constipation, heartburn, fatigue, food noise, and the rest - plus unlimited custom symptoms, each on a 0-10 severity scale with a timestamp
We dont think youll need a further explanation here